Oxybutynin for Post-surgical Bladder Pain and Urgency
Part of paid clinical trials in Sacramento, California.
- Sponsor
- University of California, Davis
- Study ID
- NCT03952299
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Neuropathic Bladder
- Overactive Bladder Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 4 Years - 8 Years
- Healthy Volunteers
- Not accepted
Interventions
- Oxybutynin Transdermal Patch — DRUGTransdermal patch of oxybutynin will be used instead of oral oxybutynin.
- Oral Oxybutynin — DRUGOral administration of oxybutynin (5mg) every 8 hours in the hospital.
Study Details
Bladder pain and urgency are common after bladder surgery. The objective is to determine if transdermal administration is superior to oral administration in alleviating pain and urgency.
Key Dates
- Start date
- Sep 1, 2021
- Status verified
- Jan 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Oral administrationOral oxybutynin (5mg) is administered in the preoperative area prior to surgery. The current regimen is to mix the oxybutynin with the standard preoperative Versed so children do not have to take two dosages. Post-operatively oral oxybutynin (5mg) is administered every 8 hours in the hospital.
- Experimental: Transdermal administrationGuardian will be given the transdermal patch (3.9mg oxybutynin) at the preoperative appointment with instructions to apply the day prior to surgery. While in the hospital no oral oxybutynin will be prescribed.
Primary Outcome Measure
Urgency Scores [ Time Frame: Preoperative (one week to two months) to postoperative period (six weeks). ]
Central Contacts
- Anjali Vij, BS9167345173
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California Davis Medical Center (UCDMC) | Sacramento | California | 95817 |
Find similar trials in Sacramento, CA
Related Studies
- Improving Overactive Bladder Treatment Access and AdherenceRecruiting · Stanford University · Redwood City, California
- Transvaginal Detrusor Nerve Radiofrequency Ablation for Treatment of Overactive BladderEnrolling By Invitation · InMode MD Ltd. · Corona del Mar, California
- BTL Emsella Chair Versus Sham for the Treatment of Overactive BladderRecruiting · Corewell Health East · Royal Oak, Michigan
- Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder SyndromePHASE4 · Recruiting · Walter Reed National Military Medical Center · Bethesda, Maryland